Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre
- PMID: 1664937
- DOI: 10.1007/BF00370302
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre
Abstract
The effects of 0.15-250 microM riluzole, a novel psychotropic agent with anticonvulsant properties, were studied on voltage-clamped nodes of Ranvier of isolated nerve fibres of the frog. When added to the external solution, the drug rapidly and reversibly inhibited both K and Na currents with an apparent dissociation constant of 0.09 mM. The riluzole-induced decrease of these currents was not "use-dependent". At concentrations up to 100 microM, the drug had no noticeable effect on the time course of Na current inactivation nor on the shape and the position along voltage axis of the Na conductance/voltage relationship. On the other hand, it induced substantial shifts towards negative voltages of the steady-state Na inactivation/voltage curve. From these results, according to the modulated-receptor model, an apparent dissociation constant of 0.29 microM could be calculated for riluzole-induced blockage of inactivated Na channels. The recovery from Na current inactivation was also affected by the drug. It is concluded that riluzole is a highly specific blocker of inactivated Na channels, which is more than 300 times more effective on these channels than on K or resting Na channels.
Similar articles
-
Interactions between molecules of a steroid anaesthetic (alphaxalone) and ionic channels of nodal membrane in voltage-clamped myelinated nerve fibre.Br J Pharmacol. 1988 Jul;94(3):635-46. doi: 10.1111/j.1476-5381.1988.tb11570.x. Br J Pharmacol. 1988. PMID: 2460175 Free PMC article.
-
Fast K channels are more sensitive to riluzole than slow K channels in myelinated nerve fibre.Pflugers Arch. 1993 Feb;422(5):536-8. doi: 10.1007/BF00375084. Pflugers Arch. 1993. PMID: 8474857
-
Mechanism of action of a structural analog of alphaxalone on myelinated nerve fibre.Eur J Pharmacol. 1988 Dec 6;158(1-2):1-9. doi: 10.1016/0014-2999(88)90246-4. Eur J Pharmacol. 1988. PMID: 2851452
-
Ion channel redistribution and function during development of the myelinated axon.J Neurobiol. 1998 Oct;37(1):80-96. J Neurobiol. 1998. PMID: 9777734 Review.
-
Sodium and potassium channel modulators: their role in neuroprotection.Int Rev Neurobiol. 1997;40:109-35. doi: 10.1016/s0074-7742(08)60718-7. Int Rev Neurobiol. 1997. PMID: 8989619 Review. No abstract available.
Cited by
-
Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial.EBioMedicine. 2015 Dec 1;2(12):1916-22. doi: 10.1016/j.ebiom.2015.11.022. eCollection 2015 Dec. EBioMedicine. 2015. PMID: 26844270 Free PMC article. Clinical Trial.
-
Left-shifted nav channels in injured bilayer: primary targets for neuroprotective nav antagonists?Front Pharmacol. 2012 Feb 23;3:19. doi: 10.3389/fphar.2012.00019. eCollection 2012. Front Pharmacol. 2012. PMID: 22375118 Free PMC article.
-
Sodium currents in medullary neurons isolated from the pre-Bötzinger complex region.J Neurosci. 2005 May 25;25(21):5159-70. doi: 10.1523/JNEUROSCI.4238-04.2005. J Neurosci. 2005. PMID: 15917456 Free PMC article.
-
Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis.Drugs. 1996 Oct;52(4):549-63. doi: 10.2165/00003495-199652040-00010. Drugs. 1996. PMID: 8891467 Review.
-
Dysbiosis and Neurodegeneration in ALS: Unraveling the Gut-Brain Axis.Neuromolecular Med. 2025 Jul 3;27(1):50. doi: 10.1007/s12017-025-08870-0. Neuromolecular Med. 2025. PMID: 40608189 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical